You Searched For "gsk" and got 20 results
Sort By:
3 mins read
Thom Felicia, member of 'Queer Eye' cast, believes that donating bone marrow to his brother was the best thing he has ever done
Twenty years ago, I impacted the world as an original 'Queer Eye' cast member. But the most meaning…
Kelly Burch
2 mins read
Inside a new $275 million fund for biotech startups
These are Insider's biggest healthcare stories for November 4.
Leah Rosenbaum
2 mins read
Upstart insurers struggle - The future of GSK - Experts are masking up
These are Insider's biggest healthcare stories for July 6.
Lydia Ramsey Pflanzer
2 mins read
A Wharton MBA grad and a former GSK exec’s healthcare startup raises $3 million to reach more PCOS patients
In August 2020, sisters Shobhita and Shashwata Narain founded Veera Health to provide “medical care…
2 mins read
India's drug controller grants approval to Sanofi and Glaxo Smith Kline to conduct Phase-3 trials of their COVID-19 vaccine
The global, randomised, double-blind Phase-III study will include more than 35,000 volunteers ag…
2 mins read
A new Alzheimer's drug exposes a 'fundamentally flawed' part of how the US pays for drugs
These are Insider's biggest healthcare stories for June 23.
Andrew Dunn
2 mins read
The 20 fastest-growing, highest-paying biotechs
These are Insider's biggest healthcare stories for June 21.
Lydia Ramsey Pflanzer
2 mins read
These are the fastest-growing biotech companies
These are Insider's biggest healthcare stories for May 18.
Lydia Ramsey Pflanzer
2 mins read
GlaxoSmithKline is facing an uncertain vaccine future
These are Insider's biggest healthcare stories for April 13.
Lydia Ramsey Pflanzer
3 mins read
GSK and Sanofi delay the expected rollout of their COVID-19 vaccine until late 2021 because of an insufficient response in older people. The US has ordered 100 million doses.
The pharmaceutical giants GlaxoSmithKline and Sanofi said they'd improve their formulation and star…
Grace Dean
4 mins read
When my daughter's asthma medication doubled in cost, I learned we weren't the only ones paying a premium to breathe
After my daughter's asthma medicine doubled in cost, I learned I wasn't the only one paying a premi…
Phoebe Farag Mikhail
1 min read
Sanofi, GSK to seek authorisation for COVID-19 vaccine
Late-stage trials found that two doses of the vaccine were about 58% effective in preventing infect…
4 mins read
A woman is trying out a 4-dose Lyme disease vaccine as we approach the worst summer for ticks yet
Pfizer's Lyme vaccine trial, if successful, could herald the first major advance in the fight again…
Hilary Brueck
1 min read
Drugmakers Sanofi and GSK launch human trials for COVID-19 vaccine
The major European drug companies have begun testing their coronavirus vaccine on humans in the US …
Kate Duffy
4 mins read
Incredible medical breakthroughs of 2022, from treating blood cancer to slowing Alzheimer's disease
A vaccine for RSV and a drug that may slow the progression of Alzheimer's disease are among the gre…
Catherine Schuster-Bruce
3 mins read
Strep A is surging in the UK and has already killed at least 19 children. Here's why it's taken so long to make a vaccine against this deadly pathogen.
Some researchers are working on a strep-A vaccine, but it will be a long time before one is availab…
Sarah Braner
2 mins read
20 years ago, a Lyme-disease vaccine was taken off the market. Now, 2 companies are developing one that could be available by 2025.
Pfizer and Valneva have said their vaccine produced immunity in phase 2 trials. If phase 3 pans out…
Sarah Braner
3 mins read
How the founder of SiriusXM wants to tackle an organ shortage with 3D-printed hearts and lungs
After founding SiriusXM in the 1990s, Martine Rothblatt is now running a biotech pushing the bounda…
Andrew Dunn
1 min read
GSK climbs 6% on report of Elliot Management's multibillion stake
Elliott enters the picture amid GSK's struggle to come back after falling behind in the COVID-19 va…
Isabelle Lee
4 mins read
Vaccines for RSV, the illness that's been sickening babies across the US, are poised to become available in 2023
Scientists were 'afraid' to develop an RSV vaccine after one trialed in the '60s made kids sicker. …